OIMEC(002819)

Search documents
东方中科:关于调整2020年股票期权与限制性股票激励计划股票期权行权价格的公告
2023-08-29 12:31
激励计划股票期权行权价格的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整, 没有虚假记载、误导性陈述或重大遗漏。 北京东方中科集成科技股份有限公司(以下简称"公司")于 2023 年 8 月 29 日召开第五届董事会第二十一会议和第五届监事会第十八 次会议,审议通过了《关于调整 2020 年股票期权与限制性股票激励 计划股票期权行权价格的议案》,同意对 2020 年股票期权与限制性 股票激励计划授予的股票期权行权价格进行调整。现将相关事项公告 如下: 一、本激励计划已履行的相关审批程序 证券代码:002819 证券简称:东方中科 公告编号:2023-067 北京东方中科集成科技股份有限公司 关于调整 2020 年股票期权与限制性股票 1、2020 年 4 月 28 日,公司第四届董事会第十九次会议审议通 过了《关于<北京东方中科集成科技股份有限公司 2020 年股票期权与 限制性股票激励计划(草案)>及其摘要的议案》《关于公司<2020 年 股票期权与限制性股票激励计划实施考核管理办法>的议案》等相关 议案。公司第四届监事会第十七次会议审议通过上述相关议案并发表 同意意见。公司独立董事对相关事 ...
东方中科:半年报监事会决议公告
2023-08-29 12:31
证券代码:002819 证券简称:东方中科 公告编号:2023-065 北京东方中科集成科技股份有限公司 第五届监事会第十八次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整, 没有虚假记载、误导性陈述或重大遗漏。 北京东方中科集成科技股份有限公司第五届监事会第十八次会 议于 2023 年 8 月 29 日以通讯方式召开,会议以投票方式表决。会议 通知已于 2023 年 8 月 18 日通过专人送达、邮件等方式送达给全体监 事。本次会议应到监事 3 名,实到监事 3 名。会议的召集、召开程序 符合《公司法》和《公司章程》的有关规定。 会议由监事会主席魏伟女士主持,与会监事对各项议案进行审议、 表决,形成如下决议: 1、审议通过《<2023 年半年度报告全文>及摘要》 经审核,监事会认为:董事会编制和审议的公司《<2023 年半年 度报告全文>及摘要》的程序符合法律、行政法规及中国证监会的规 定,报告内容真实、准确、完整地反映了上市公司的实际情况,不存 在任何虚假记载、误导性陈述或者重大遗漏。 2、审议通过《董事会关于 2023 年半年度募集资金存放与使用情 况的专项报告》 经审核,监事会 ...
东方中科:2022年度分红派息实施公告
2023-08-08 09:58
证券代码:002819 证券简称:东方中科 公告编号:2023-063 北京东方中科集成科技股份有限公司 2022年度分红派息实施公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整, 没有虚假记载、误导性陈述或重大遗漏。 特别提示: 北京东方中科集成科技股份有限公司(以下简称"本公司"或"公 司")2022 年年度利润分配预案已经 2023 年 6 月 30 日召开的 2022 年年度股东大会审议通过。现将利润分配方案实施事宜公告如下: 一、股东大会审议通过权益分派方案等情况 1、公司2022年度股东大会审议通过的分派方案为:以截至2023 年4月10日公司总股本305,846,302股剔除回购专户上 已回 购股份 51,300股后的总股本305,795,002股为基数,向全体股东每10股派发现 金0.6元人民币(含税),预计分配现金红利约18,347,700.12元,不送 红股,不以资本公积金转增股本。 自分配预案披露至实施利润分配的股权登记日期间,公司股本若 因新增股份上市、股权激励行权、可转债转股、股份回购等原因发生 变化的,将按照分配比例不变的原则对现金股利总额进行相应调整。 2、自分配方 ...
东方中科(002819) - 2023 Q1 - 季度财报
2023-04-28 16:00
Financial Performance - The net loss for the first quarter was CNY 53,905,786.84, compared to a net loss of CNY 13,796,328.43 in the same period last year, representing an increase in loss of approximately 290.5%[25] - The operating profit showed a loss of CNY 57,139,250.80, worsening from a loss of CNY 13,602,920.55 year-over-year[25] - The net profit attributable to shareholders was -¥33,421,489.70, representing a decrease of 276.45% from -¥8,878,144.75 in the same period last year[31] - The weighted average return on net assets was -1.00%, compared to -0.23% in the previous year[31] - The net loss attributable to the parent company was ¥33,421,489.70, compared to a loss of ¥8,878,144.75 in the previous period, indicating a significant decline in profitability[44] - Basic earnings per share for the current period were -0.1093, worsening from -0.0279 in the previous period[44] Revenue and Costs - The company's operating revenue for Q1 2023 was ¥632,625,421.53, an increase of 9.94% compared to ¥575,407,115.00 in the previous year[31] - Total operating revenue for the current period reached ¥632,625,421.53, an increase of 9.2% compared to ¥575,407,115.00 in the previous period[41] - Total operating costs amounted to ¥697,736,031.27, up 16.7% from ¥597,912,459.48 in the prior period, with operating costs specifically rising from ¥476,350,161.99 to ¥521,346,586.59[41] Assets and Liabilities - Total non-current assets increased by 43.89% to ¥15,463,960.06 compared to the beginning of the period[6] - The total assets decreased from CNY 5,154,039,762.40 to CNY 4,992,804,836.01, a decline of approximately 3.14%[21] - The company's long-term equity investments increased from CNY 3,327,050.35 to CNY 3,976,005.61, reflecting a growth of approximately 19.5%[21] - The total non-current liabilities decreased from CNY 1,220,157,594.86 to CNY 1,111,417,452.70, a reduction of about 8.9%[21] - The company’s total liabilities decreased from CNY 3,017,197,357.54 to CNY 2,933,000,000.00, a decrease of approximately 2.8%[21] - The total liabilities decreased to ¥1,209,353,400.98 from ¥1,319,761,714.24, reflecting a reduction in financial obligations[41] - The total equity attributable to shareholders decreased to ¥3,322,894,791.00 from ¥3,353,237,106.99, indicating a decline in shareholder value[41] Cash Flow - Net cash flow from investment activities surged by 222.04% to ¥73,408,311.15, mainly due to the maturity of financial products[7] - Net cash flow from financing activities improved by 145.81% to ¥23,796,457.93, resulting from increased borrowings[7] - The net cash flow from operating activities was -¥281,978,395.69, a decline of 21.88% compared to -¥231,354,219.53 in the previous year[31] - The company reported a net cash outflow of ¥184,448,922.90 in the current period, compared to an outflow of ¥260,216,174.67 in the previous period, indicating improved cash management[47] - Cash received from operating activities totaled ¥1,308,889,335.25, up from ¥1,007,502,506.51 in the previous year[27] - Cash paid for purchasing goods and services was ¥831,286,617.29, an increase from ¥551,190,470.24 in the previous year[27] - The cash flow from investment activities included cash recovered from investments amounting to ¥168,228,356.16, up from ¥130,000,000.00 in the previous year[27] - The company experienced a decline in cash and cash equivalents, with a balance of ¥1,066,248,282.06 at the end of the reporting period, down from ¥1,274,591,208.39 at the beginning of the year[38] - Cash and cash equivalents at the end of the period were ¥1,048,568,961.33, down from ¥1,267,542,401.09 at the end of the previous period[47] Expenses - Management expenses rose by 81.80% to ¥57,486,308.77, primarily due to the addition of new subsidiaries[6] - R&D expenses increased by 46.72% to ¥56,871,799.61, reflecting a stronger focus on research and development initiatives[6] - Research and development expenses increased to ¥56,871,799.61 from ¥38,763,100.64, highlighting a focus on innovation[41] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 17,166[7] - The largest shareholder, Dongfang Keyi Holdings Group Co., Ltd., holds 24.87% of the shares[7] Other Financial Metrics - Credit impairment losses increased by 136.55% to -¥3,962,618.82, indicating a rise in provisions for credit losses[7] - Asset disposal gains rose significantly by 3532.37% to ¥2,608,327.71, due to increased income from leasing asset disposals[7] - The company reported a significant increase in other comprehensive income, which was not detailed in the provided data, suggesting potential improvements in investment performance[25] - The company’s deferred tax assets increased from CNY 54,427,754.13 to CNY 61,927,962.02, an increase of about 13.8%[21] - The company is focusing on enhancing its investment strategies and exploring new market opportunities, although specific details were not provided in the report[25]
东方中科(002819) - 2022 Q4 - 年度财报
2023-04-11 16:00
Financial Performance - The total operating revenue for Q4 2022 was approximately CNY 1.27 billion, showing a significant increase compared to previous quarters[13]. - The net profit attributable to shareholders for Q4 2022 was CNY 907.13 million, a recovery from a loss in the previous quarter[13]. - The company reported a net cash flow from operating activities of CNY 84.28 million in Q4 2022, indicating improved cash generation[13]. - The company's operating revenue for 2022 was CNY 3,022,814,268.86, an increase from CNY 1,848,389,467.26 in 2021, representing a growth of approximately 63.5%[55]. - The net profit attributable to shareholders for 2022 was ¥888,840,608.20, a significant increase of 417.19% from ¥171,858,699.94 in 2021[70]. - The basic earnings per share for 2022 was ¥2.8712, up 183.83% from ¥1.0116 in 2021[70]. - The company reported a significant increase in revenue, achieving a total of 1.2 billion CNY, representing a 15% year-over-year growth[92]. - The company reported a net profit margin of 12%, up from 10% in the previous year, indicating improved operational efficiency[92]. Asset Management - The total non-current asset disposal gain for 2022 was CNY 897,850.18, primarily from fixed asset disposals[14]. - The total liabilities of the company at the end of 2022 were reported to be CNY 2.5 billion, reflecting a stable financial position[18]. - The total assets at the end of 2022 were ¥5,154,039,762.40, a decrease of 2.27% from ¥5,273,831,637.82 at the end of 2021[70]. - The net assets attributable to shareholders decreased by 12.97% to ¥3,353,237,106.99 at the end of 2022 from ¥3,852,869,981.60 at the end of 2021[70]. - The total assets of the company increased to 3 billion CNY, reflecting a 10% growth from the previous fiscal year[92]. Cash Flow and Investments - The company reported a net cash flow from operating activities of -¥130,715,792.30 in 2022, a decline of 153.47% compared to ¥244,473,998.14 in 2021[70]. - The company achieved a significant investment income of CNY 1.00 billion from trading financial assets in 2022, a notable recovery from a loss in the previous year[15]. - The company reported a total of 52,300 million yuan in entrusted financial management, with an outstanding balance of 17,405 million yuan[183]. - The company’s financial management includes 38,000 million yuan in bank financial products and 8,000 million yuan in securities financial products, all sourced from self-owned funds[183]. Strategic Plans and Market Expansion - The company plans to expand its market presence and invest in new technologies, although specific financial targets were not disclosed[18]. - The company is focusing on strategic acquisitions to enhance its competitive edge in the market[18]. - The company plans to enhance market research for its self-operated leasing assets to mitigate risks associated with technological obsolescence[78]. - Market expansion plans include entering two new international markets by Q3 2023, aiming for a 5% market share in each[92]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of 300 million CNY for potential deals[92]. Research and Development - The company is actively engaged in research and development of new technologies to enhance its market position and expand its product offerings[55]. - The company is investing in R&D, allocating 150 million CNY towards the development of new technologies and products[92]. - The company has invested significantly in R&D, impacting its financial performance in recent years[195]. Corporate Governance and Compliance - The company has committed to ensuring the accuracy and completeness of its financial reports, as stated by the management team[43]. - The company has not reported any significant discrepancies between its financial indicators and previously disclosed quarterly or semi-annual reports[56]. - The company is focusing on improving its corporate governance structure to ensure compliance with listing requirements and protect minority shareholders' rights[80]. - The company has not faced any penalties or violations during the reporting period[118]. - The company has not identified any major defects in its non-financial reporting, indicating a strong governance framework[143]. Employee Management - The total number of employees at the end of the reporting period was 1,805, with 299 in the parent company and 1,506 in major subsidiaries[103]. - The company has established a fair and effective evaluation system for senior management, with performance assessments based on operational results[110]. - The company will continue to optimize its compensation management system to enhance market competitiveness and employee retention[131]. - The company has conducted internal control training for all employees to enhance risk control awareness and compliance[140]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 13,667, down from 17,166 at the end of the previous month[154]. - The largest shareholder, Dongfang Keyi Holding Group Co., Ltd., holds 24.87% of the shares, totaling 76,064,719 shares[155]. - The company repurchased and canceled 12,831,427 shares due to the failure of Wanlihong to meet the 2021 performance commitment, reducing the total share capital from 318,179,769 to 305,348,342 shares[152]. - The shareholding structure shows that the top 10 shareholders hold a significant portion of the company's equity, with the top three shareholders alone accounting for over 50%[155]. Performance Commitments - The company committed to achieving performance targets of CNY 71 million, 210 million, 310 million, and 390 million over four years, with ongoing fulfillment[122]. - The company's performance commitment for the reporting period was not met, triggering compensation obligations from the performance commitment party[174]. - Wanlihong's net profit for 2020, 2021, and 2022 was 71.13 million, 111.64 million, and -114.06 million RMB respectively, with a cumulative net profit of 70.69 million RMB[195]. - The company's commitment to net profit for the same years was 71 million, 210 million, and 310 million RMB, totaling 591 million RMB[195].
东方中科:关于举办2022年度业绩网上说明会的公告
2023-04-11 12:54
证券代码:002819 证券简称:东方中科 公告编号:2023-023 北京东方中科集成科技股份有限公司 关于举办 2022 年度业绩网上说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整, 没有虚假记载、误导性陈述或重大遗漏。 1、会议召开时间:2023 年 04 月 21 日(星期五)15:00-17:00 2、会议召开方式:网络互动方式 3、会议召开地点:价值在线(www.ir-online.cn) 4、会议问题征集:投资者可于 2023 年 04 月 21 日前访问网址 https://eseb.cn/13HEKeEVIAw 或使用微信扫描下方小程序码进行会 前提问,公司将通过本次业绩说明会,在信息披露允许范围内就投资 者普遍关注的问题进行回答。 北京东方中科集成科技股份有限公司(以下简称"公司")已于 2023 年 4 月 12 日在巨潮资讯网上披露了《2022 年年度报告》及《2022 年年度报告摘要》。为便于广大投资者更加全面深入地了解公司经营 业绩、发展战略等情况,公司定于 2023 年 04 月 21 日(星期五)15:00- 17:00 在"价值在线"(www.ir-o ...
东方中科(002819) - 2022 Q3 - 季度财报
2022-10-27 16:00
Financial Performance - The company's revenue for Q3 2022 reached ¥597,019,859.74, representing a 60.61% increase year-over-year[7] - The net profit attributable to shareholders was a loss of ¥15,756,008.99, a decline of 163.73% compared to the same period last year[7] - The company reported a 71.66% increase in total revenue for the first nine months of 2022, totaling ¥1,749,858,430.26[12] - Net profit for the period was -$38,489,048.28, a decrease of 168.82% compared to $55,928,500.25 in the previous year, primarily due to seasonal losses in the Wanlihong business[15] - The net profit for the third quarter was -38,489,048.28 CNY, compared to a profit of 55,928,500.25 CNY in the same period last year, indicating a significant decline[36] - The total operating profit was -25,985,918.28 CNY, down from 67,792,100.05 CNY year-over-year[36] - The company reported a total of ¥905,424.49 in non-recurring gains and losses for the current period[8] - The total comprehensive income for the period was -38,489,048.28 CNY, compared to 55,928,500.25 CNY in the previous year[36] Cash Flow and Expenses - The operating cash flow net amount was -¥214,992,222.38, reflecting a significant decrease of 619.45% year-over-year[7] - Cash received from sales of goods and services increased by 72.90% to $1,880,159,305.69 from $1,087,457,177.98, mainly due to increased cash flow from Wanlihong and instrument sales[15] - Cash received from other operating activities rose by 47.92% to $307,928,337.13, attributed to increased cash flow from Wanlihong and higher deposits from bidding agency services[15] - Cash paid to employees surged by 272.90% to $299,487,932.24 from $80,312,568.46, reflecting increased cash flow payments to employees in the Wanlihong business[15] - Cash paid for purchasing goods and services rose by 60.53% to $1,549,554,523.43, mainly due to increased inventory and daily procurement payments[15] - Cash inflow from bank loans increased dramatically by 3600.00% to $37,000,000.00, reflecting a significant rise in bank borrowings during the period[15] - Cash flow from operating activities showed a net outflow of -214,992,222.38 CNY, contrasting with a net inflow of 41,388,053.32 CNY in the previous year[37] - Investment activities resulted in a net cash outflow of -107,998,712.01 CNY, compared to a net inflow of 17,651,491.56 CNY last year[40] Assets and Liabilities - Total assets as of the end of Q3 2022 were ¥5,170,369,729.99, down 1.96% from the end of the previous year[7] - The company's cash and cash equivalents decreased to ¥1,230,429,719.88 from ¥1,548,083,333.35, a decline of about 20.5%[23] - The total assets decreased to ¥5,170,369,729.99 from ¥5,273,831,637.82, a reduction of approximately 1.9%[29] - Total liabilities decreased to ¥933,888,864.86 from ¥957,162,546.16, indicating a decline of about 2.4%[29] - The equity attributable to shareholders decreased to ¥3,796,794,954.88 from ¥3,852,869,981.60, a decrease of approximately 1.5%[29] Research and Development - Research and development expenses surged by 412.30% to ¥135,880,417.45 in the first nine months of 2022[12] - Research and development expenses surged to ¥135,880,417.45, compared to ¥26,523,469.68 in the previous year, reflecting an increase of approximately 412.5%[30] - The company is focusing on expanding its market presence and enhancing its product offerings through ongoing research and development initiatives[30] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 14,685, with the largest shareholder, Dongfang Keyi Holdings Group Co., Ltd., holding 24.90%[18] - The company approved the exercise of stock options and the lifting of restrictions on 63,178.5 thousand shares for 27 eligible participants, effective from August 1, 2022[22]
东方中科(002819) - 2022 Q2 - 季度财报
2022-08-24 16:00
Financial Performance - The company's operating revenue for the first half of 2022 was ¥1,152,838,570.52, representing a 78.00% increase compared to ¥647,647,496.91 in the same period last year[26]. - The net profit attributable to shareholders was a loss of ¥2,538,034.92, a decrease of 110.94% from a profit of ¥23,207,583.67 in the previous year[26]. - The net cash flow from operating activities was -¥118,001,002.88, which is an 85.03% decline compared to -¥63,774,792.31 in the same period last year[26]. - The basic earnings per share were -¥0.0080, down 105.50% from ¥0.1455 in the previous year[26]. - Total assets at the end of the reporting period were ¥5,061,927,652.20, a decrease of 4.02% from ¥5,273,831,637.82 at the end of the previous year[26]. - The net assets attributable to shareholders were ¥3,806,207,573.08, down 1.21% from ¥3,852,869,981.60 at the end of the previous year[26]. - The company's gross profit margin was 15.69%, a decrease of 1.37% from the previous year[125]. Revenue Breakdown - Revenue from the testing technology and services sector was ¥803,735,455.77, with a year-on-year increase of 24.10%[34]. - The newly added digital security and confidentiality sector generated revenue of ¥349,103,114.75, with significant profits expected in the second half of the year[34]. - The revenue from the testing technology and services segment was ¥803,735,455.77, accounting for 69.72% of total revenue, while the digital security and confidentiality segment contributed ¥349,103,114.75, or 30.28%[121]. - The sales revenue from instrument sales was ¥709,152,320.17, reflecting an 11.49% increase compared to the previous year[125]. - The bidding agency business saw a significant revenue increase of 70.34%, totaling ¥25,631,609.76[125]. - The revenue from the iris recognition business grew by 48.50%, amounting to ¥7,728,392.19[125]. Strategic Focus and Challenges - The company faced significant challenges leading to a substantial decline in net profit and cash flow, indicating potential risks in its operations[26]. - The company is focusing on new product development and market expansion strategies to improve future performance[26]. - The company aims to provide tailored solutions based on customer needs, ensuring compliance with information security requirements[61]. - The company plans to reduce reliance on instrument procurement by increasing the proportion of self-operated leasing business and expanding into non-U.S. instrument brands[159]. - The company faces risks related to delayed customer demand and supply chain constraints, particularly due to U.S.-China trade tensions, and is enhancing service capabilities to mitigate these risks[158][159]. Research and Development - Research and development expenses surged by 343.98% to ¥85,019,059.65 from ¥19,149,393.75, reflecting increased investment in technology and product development[120]. - The company focuses on high-tech industries such as 5G, new energy vehicles, and advanced manufacturing, increasing R&D investments in testing applications[36]. - The company is enhancing its R&D capabilities by expanding its team and establishing multiple research branches across the country[103]. Market Presence and Customer Base - The company has established a nationwide marketing network with branches in over 30 major cities, ensuring localized service support[39]. - The company established a strong customer base with approximately 4,000 clients across various industries, including research institutions and sectors such as telecommunications and electronics[110]. - The company operates a multi-brand strategy with nearly 20 officially represented brands and over 200 instrument brands, offering more than 3,000 models[37]. Product Offerings - The company has developed a comprehensive product line in the information security and confidentiality field, covering multiple aspects such as network security audits and access control[114]. - The company’s electronic measurement instruments include signal generators, voltage measuring instruments, frequency and time measuring instruments, and signal analyzers, among others[56]. - The company has established a complete product line for information security, including comprehensive confidentiality management systems and network security audits, enabling a multi-faceted approach to information security[61]. Financial Management and Investments - The total investment amount during the reporting period was ¥330,000,000.00, representing a significant increase of 450.00% compared to the previous year[137]. - The company had cash and cash equivalents of ¥2,972,430.59, which were restricted due to performance guarantees and letter of credit guarantees[136]. - The company reported a significant increase in the bidding agency business due to market recovery and increased project settlements[128]. Corporate Governance and Compliance - The company did not engage in any derivative investments during the reporting period[141]. - The semi-annual financial report was not audited[179]. - There were no violations regarding external guarantees during the reporting period[178]. - The company did not experience any major litigation or arbitration matters during the reporting period[181].
东方中科(002819) - 2022 Q1 - 季度财报
2022-04-26 16:00
Financial Performance - The company's operating revenue for Q1 2022 was ¥575,407,115, representing a 109.55% increase compared to ¥274,592,338 in the same period last year[5]. - The net profit attributable to shareholders was a loss of ¥8,878,144.75, a decrease of 217.35% from a profit of ¥7,565,354.59 in the previous year[5]. - The net profit for the period was -13,796,328.43, a decrease of 246.42% compared to the previous year, primarily due to seasonal losses in the Wanlihong business[11]. - The net profit attributable to the parent company was -8,878,144.75, reflecting a decrease of 217.35% year-on-year, also due to seasonal losses in the Wanlihong business[11]. - Basic earnings per share decreased to -¥0.0279, down 158.86% from ¥0.0474 in the previous year[5]. - The net profit for the period was a loss of CNY 13,796,328.43, compared to a profit of CNY 9,422,130.23 in the same period last year, reflecting a decline in profitability[30]. Cash Flow and Liquidity - The net cash flow from operating activities was -¥231,354,219.53, worsening by 252.25% compared to -¥65,679,600.58 in the same period last year[5]. - Cash received from sales of goods and services increased by 79.41% to 504,651,470.40, driven by increased cash flow from Wanlihong and instrument sales[11]. - Cash received from factoring increased by 38.82% to 417,350,316.07, indicating a rise in the recovery of commercial factoring[11]. - Cash paid for purchasing goods and services rose by 100.77% to 551,190,470.24, attributed to increased payments for project stocking and daily inventory[11]. - Cash paid to employees increased by 210.93% to 99,023,479.24, reflecting higher cash flow payments to employees in the Wanlihong business[11]. - The company's cash and cash equivalents at the end of the period were 1,327,695,728.03, down from 1,548,083,333.35 at the beginning of the year[19]. - Cash inflows from operating activities totaling CNY 1,007,502,506.51, an increase of 60.9% compared to CNY 625,560,621.21 in the previous period[37]. - Cash outflows from operating activities amounted to CNY 1,238,856,726.04, up from CNY 691,240,221.79, resulting in a net cash flow from operating activities of CNY -231,354,219.53, compared to CNY -65,679,600.58 last period[37]. Assets and Liabilities - Total assets at the end of the reporting period were ¥5,169,614,917.80, a decrease of 1.98% from ¥5,273,831,637.82 at the end of the previous year[5]. - Total current assets decreased to 4,098,672,545.46 from 4,194,078,963.76 at the beginning of the year[19]. - Total liabilities decreased to CNY 871,253,022.08 from CNY 957,162,546.16, representing a decline of approximately 9.0%[25]. - The company's total equity decreased slightly to CNY 4,298,361,895.72 from CNY 4,316,669,091.66, reflecting a decrease of about 0.42%[25]. Research and Development - The company reported a significant increase in research and development expenses, which rose by 287.07% to ¥38,763,100.64 compared to ¥10,014,601.37 in the previous year[8]. - Research and development expenses reached CNY 38,763,100.64, significantly higher than CNY 10,014,601.37 in the previous year, marking an increase of approximately 287.5%[30]. - The company is focusing on expanding its market presence and enhancing its product offerings, as indicated by the significant increase in R&D expenses[30]. Financing Activities - The company’s short-term borrowings increased by 200% to ¥3,003,097.22 from ¥1,001,041.67, indicating a rise in bank financing[8]. - Cash inflows from financing activities totaled CNY 22,000,000.00, a decrease from CNY 30,000,000.00, while cash outflows increased to CNY 73,946,654.44 from CNY 22,033,779.18[40]. - The net cash flow from financing activities was CNY -51,946,654.44, compared to CNY 7,966,220.82 in the previous period[40]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 9,487, with the largest shareholder, Dongfang Keyi Holdings Group Co., Ltd., holding 23.91%[12]. Other Information - The company reported a government subsidy of ¥310,000, contributing to its non-operating income[7]. - The company did not undergo an audit for the first quarter report[41].
东方中科(002819) - 2021 Q4 - 年度财报
2022-03-28 16:00
Financial Performance - The company reported a total revenue of 318,168,998 CNY for the year 2021, with a cash dividend of 1.50 CNY per 10 shares distributed to all shareholders[6]. - The company's operating revenue for 2021 was ¥1,848,389,467.26, representing a 63.58% increase compared to ¥1,129,966,213.42 in 2020[29]. - The net profit attributable to shareholders for 2021 was ¥171,858,699.94, a significant increase of 212.22% from ¥55,044,402.33 in 2020[29]. - The net cash flow from operating activities reached ¥244,473,998.14 in 2021, up 169.33% from ¥90,769,525.10 in 2020[29]. - Total assets at the end of 2021 amounted to ¥5,273,831,637.82, a 394.48% increase from ¥1,066,541,854.58 at the end of 2020[32]. - The company's net assets attributable to shareholders increased to ¥3,852,869,981.60, reflecting a 601.65% growth from ¥549,115,674.83 in 2020[32]. - The basic earnings per share for 2021 was ¥1.0116, representing a 187.96% increase compared to ¥0.3513 in 2020[29]. - The company reported a net profit of ¥123,929,091.33 in Q4 2021, significantly higher than previous quarters, indicating strong performance in the last quarter[35]. - The weighted average return on equity for 2021 was 18.50%, an increase from 10.03% in 2020, showcasing improved profitability[29]. Corporate Governance and Structure - The company emphasizes the importance of accurate financial reporting, with key executives affirming the authenticity and completeness of the annual report[5]. - The company is committed to transparency, with all board members present for the report's review, ensuring accountability[6]. - The company has maintained its main business operations without any changes since its listing, indicating stability in its core activities[27]. - The company has not experienced any changes in its controlling shareholders since its establishment, reflecting consistent ownership[27]. - The company has not made any changes to its organizational code since its inception, indicating stability in its corporate structure[27]. - The company has a dedicated investor relations team, ensuring effective communication with shareholders and stakeholders[23]. - The company has established branches in over 30 major cities across China, enhancing its ability to respond quickly to customer needs[89]. - The company has a strong management resource advantage, having built a solid management foundation and a replicable management methodology since its establishment[146]. Market and Industry Trends - The demand for electronic testing and measurement instruments is critical across various industries, including semiconductor and telecommunications, with a focus on 5G technology[45]. - R&D investment intensity in China has been increasing, with a growth rate consistently higher than the economic growth rate[46]. - By the end of 2019, the global electronic testing market was approximately ¥84.8 billion, with China's market size at around ¥19 billion, accounting for 22% of the global market[51]. - The CAGR for China's electronic testing market is expected to exceed the global growth rate, with projections indicating that by 2025, China's market will represent 26% of the global market[51]. - In 2020, global spending on information security reached $133.8 billion, with projections for 2021 estimating it to rise to $143.5 billion[59]. - China's information security product and service revenue reached ¥149.8 billion in 2020, reflecting a year-on-year growth of 14.53%[63]. - The iris recognition market in China has seen rapid growth, with the market size surpassing ¥26 billion in 2020, accounting for 17% of the global market[69]. - The Chinese government aims for the cybersecurity industry to exceed ¥250 billion by 2023, with a compound annual growth rate of over 15%[68]. Business Strategy and Expansion - The company completed the acquisition of 78.33% of Wanlihong's equity, expanding its main business into testing technology and digital security[44]. - The company has expanded its service model through investments and acquisitions, enhancing its factoring and bidding business, which contributes to its comprehensive service model[86]. - The company focuses on high-tech industries such as 5G, new energy vehicles, and advanced intelligent manufacturing, providing comprehensive solutions for complex testing applications[86]. - The company operates a multi-brand and multi-product business model, representing nearly 20 officially partnered instrument brands and over 200 brands in total, offering more than 3,000 types of instruments[87]. - The company has established a comprehensive one-stop service model, providing a range of professional services including instrument sales, leasing, and system integration, which helps clients reduce costs and improve efficiency[148]. - The company aims to enhance its market presence and service capabilities through strategic expansions and collaborations in the bidding agency and digital security sectors[101]. Research and Development - The company's R&D investment amounted to ¥46,817,128.67 in 2021, representing a 65.20% increase from ¥28,340,174.60 in 2020[186]. - The number of R&D personnel increased to 339 in 2021, a significant rise of 308.43% compared to 83 in 2020[183]. - The R&D personnel structure has changed significantly, with a notable increase in the number of employees under 30 years old, rising by 1,200.00%[186]. - The company is actively pursuing new technology developments in the automotive sector, particularly in V2X testing and intelligent chassis testing, to maintain a technological edge[182]. Customer Base and Sales Model - The company serves a diverse customer base, including government agencies, educational institutions, and military enterprises, with tailored security solutions[111]. - The sales model primarily relies on direct sales, supplemented by intermediaries such as distributors and service providers, to broaden customer coverage[90]. - The company has a wide customer base, serving approximately 4,000 clients annually across various industries, which lays a solid foundation for stable business growth[149]. - The top five customers accounted for 12.64% of total annual sales, with total sales amounting to ¥233,680,499.01[175]. - The top five suppliers contributed 40.39% of total annual purchases, with total procurement amounting to ¥574,553,673.14[175]. Financial Management - The company reported a total operating cost of ¥1,365,414,814.15, which is 95.99% of total operating costs, showing a year-on-year increase of 58.45%[170]. - The company has reported a net increase in cash and cash equivalents of ¥1,356,734,287.67 in 2021, a dramatic rise of 3,712.93% from -¥37,552,179.17 in 2020[191]. - The net cash flow from financing activities improved significantly to ¥519,140,757.94 in 2021, compared to a negative flow of -¥53,386,488.16 in 2020, marking an increase of 1,072.42%[191]. - The company's cash and cash equivalents increased to ¥1,548,083,333.35, making up 29.35% of total assets, up from 16.22% at the beginning of the year[195]. - The company anticipates that payment collection may vary due to the approval processes of its main clients, which include government and military organizations[142].